Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

NICE ‘surprised’ at downgrading of its role

November 5, 2010 Sales and Marketing Andrew Dillon, GP prescribing deicisions, NICE, QALY, incremental cost-effectiveness ratio, value-based pricing

NICE received no warning that its health technology assessment role is to be downgraded, the watchdog’s head has admitted. In …
News
Bayer's Levitra

Bayer faces ABPI audit after “shocking” Levitra error

November 5, 2010 Medical Communications, Sales and Marketing ABPI, ABPI Code of Practice, Bayer, PMCPA

Bayer has been accused of a “shocking error of judgement” after promotional material for its erectile dysfunction brand Levitra (vardenafil) …
News

Don’t replace NICE with another ‘misguided experiment’

November 5, 2010 Sales and Marketing NHS, NICE, Stockholm Network, medicines access, risk-sharing

Replacing NICE with a similar system would be detrimental to UK healthcare, according to the Stockholm Network, which further warns …
News

NicOx to halve HQ workforce

November 4, 2010 Research and Development, Sales and Marketing NicOx, job cuts, naproxcinod, pharma jobs

French pharmaceutical company NicOx is to halve the workforce at its Sophia Antipolis headquarters and is considering restructuring its Italian …
News

Biogen set to axe 650 jobs and focus on neurology

November 4, 2010 Research and Development, Sales and Marketing Biogen, Rituxan, job cuts, pharma jobs

Biogen Idec is set to cut hundreds of jobs and refocus its R&D in an effort to cut costs by …
News
ABPI Code of Practice

UK pharma to declare doctor payments

November 4, 2010 Medical Communications, Sales and Marketing ABPI, ABPI Code of Practice, advisory boards, healthcare professionals, pharma industry standards

Pharma companies in the UK have agreed to restrict their promotional giveaways and to declare payments to doctors. Another common …
News

Doctors.net.uk boosts business development team

November 4, 2010 Sales and Marketing Doctors.net.uk, Jo Bell, Lizzie Evans, Paul Kelly, Phil Oldroyd, appointment, sales and marketing

Online healthcare professional network Doctors.net.uk has made three business development appointments and added a new project manager to its team. …
Appointment

New Commercial Realities

November 4, 2010 Sales and Marketing Kinapse, White paper

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, pharmaceutical companies must undertake a fundamental and …
Feature
White paper

Lundbeck issues Lexapro patent warning

November 3, 2010 Sales and Marketing Azilect, Cipralex, Forest Laboratories, Lexapro, Lundbeck, Xenazine

Neurological disorder specialist Lundbeck has posted a modest growth in revenue for the third quarter, but warned the looming patent …
News

Pfizer Q3 profits hit hard

November 3, 2010 Sales and Marketing Liptior sales, Pfizer, Pfzier Q3 results, Wyeth

The integration of Wyeth into Pfizer continues to drive its revenue growth, but at a cost – charges from the …
News

Nycomed expands China presence with Techpool stake

November 2, 2010 Research and Development, Sales and Marketing China, Guangdong Techpool biopharma, Nycomed, emerging markets, emerging pharma markets

Swiss-based Nycomed has acquired a majority stake in Guangdong Techpool biopharma in China, extending its presence in the top tier …
News

Lundbeck UK appoints senior management team

November 2, 2010 Research and Development, Sales and Marketing Amanda Badrick, Andy Davis, Andy Jones, Helen Carberry, Lundbeck, Steve Ferguson, appointment, recruitment, research and development, sales and marketing

Lundbeck UK has formed a new senior management team, appointing Steve Ferguson, Andy Davis, Andy Jones, Helen Carberry and Amanda …
News

Regulators must catch up with medical science, says FDA

November 2, 2010 Research and Development, Sales and Marketing Advancing Regulatory Science, Critical Path Initiative’, Dr Margaret Hamburg, FDA, regulatory affairs

The head of the FDA has declared a need for ‘regulatory science’ to catch up with the advances in medical …
News

FDA approves Novartis’ Afinitor

November 1, 2010 Sales and Marketing Afinitor, Novartis, subependymal giant cell astrocytomas, tuberous sclerosis

Novartis’ drug Afinitor has been approved by US authorities as a first line treatment for patients with benign brain tumours …
News

Pfizer to seek US approval for crizotinib next year

November 1, 2010 Research and Development, Sales and Marketing FDA submission, NSCLC, Pfizer, crizotinib, lung cancer, non-small cell lung cancer

Pfizer will submit its lung cancer candidate crizotinib to the FDA for US approval in the first half of next …
News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026